node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
AMHR2 | C7orf49 | ENSP00000257863 | ENSP00000376823 | anti-Mullerian hormone receptor, type II; On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for anti-Muellerian hormone | chromosome 7 open reading frame 49; May act as a regulator of proteasome (By similarity) | 0.747 |
AMHR2 | CTNND2 | ENSP00000257863 | ENSP00000307134 | anti-Mullerian hormone receptor, type II; On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for anti-Muellerian hormone | catenin (cadherin-associated protein), delta 2 | 0.563 |
AMHR2 | ROPN1L | ENSP00000257863 | ENSP00000274134 | anti-Mullerian hormone receptor, type II; On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for anti-Muellerian hormone | rhophilin associated tail protein 1-like | 0.404 |
C7orf49 | AMHR2 | ENSP00000376823 | ENSP00000257863 | chromosome 7 open reading frame 49; May act as a regulator of proteasome (By similarity) | anti-Mullerian hormone receptor, type II; On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for anti-Muellerian hormone | 0.747 |
C7orf49 | CDKN1C | ENSP00000376823 | ENSP00000411552 | chromosome 7 open reading frame 49; May act as a regulator of proteasome (By similarity) | cyclin-dependent kinase inhibitor 1C (p57, Kip2); Potent tight-binding inhibitor of several G1 cyclin/CDK complexes (cyclin E-CDK2, cyclin D2-CDK4, and cyclin A-CDK2) and, to lesser extent, of the mitotic cyclin B-CDC2. Negative regulator of cell proliferation. May play a role in maintenance of the non- proliferative state throughout life | 0.633 |
C7orf49 | COL10A1 | ENSP00000376823 | ENSP00000243222 | chromosome 7 open reading frame 49; May act as a regulator of proteasome (By similarity) | collagen, type X, alpha 1; Type X collagen is a product of hypertrophic chondrocytes and has been localized to presumptive mineralization zones of hyaline cartilage | 0.610 |
C7orf49 | CTNND2 | ENSP00000376823 | ENSP00000307134 | chromosome 7 open reading frame 49; May act as a regulator of proteasome (By similarity) | catenin (cadherin-associated protein), delta 2 | 0.690 |
C7orf49 | ERCC6L2 | ENSP00000376823 | ENSP00000288985 | chromosome 7 open reading frame 49; May act as a regulator of proteasome (By similarity) | excision repair cross-complementing rodent repair deficiency, complementation group 6-like 2 | 0.613 |
C7orf49 | KCNE1 | ENSP00000376823 | ENSP00000337255 | chromosome 7 open reading frame 49; May act as a regulator of proteasome (By similarity) | potassium voltage-gated channel, Isk-related family, member 1; Ancillary protein that assembles as a beta subunit with a voltage-gated potassium channel complex of pore-forming alpha subunits. Modulates the gating kinetics and enhances stability of the channel complex. Assembled with KCNQ1/KVLQT1 is proposed to form the slowly activating delayed rectifier cardiac potassium (IKs) channel. The outward current reaches its steady state only after 50 seconds. Assembled with KCNH2/HERG may modulate the rapidly activating component of the delayed rectifying potassium current in heart (IKr) | 0.563 |
C7orf49 | PRKG2 | ENSP00000376823 | ENSP00000264399 | chromosome 7 open reading frame 49; May act as a regulator of proteasome (By similarity) | protein kinase, cGMP-dependent, type II | 0.687 |
C7orf49 | ROPN1L | ENSP00000376823 | ENSP00000274134 | chromosome 7 open reading frame 49; May act as a regulator of proteasome (By similarity) | rhophilin associated tail protein 1-like | 0.562 |
C7orf49 | SLC6A3 | ENSP00000376823 | ENSP00000270349 | chromosome 7 open reading frame 49; May act as a regulator of proteasome (By similarity) | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3; Amine transporter. Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals | 0.539 |
C7orf49 | TBATA | ENSP00000376823 | ENSP00000299290 | chromosome 7 open reading frame 49; May act as a regulator of proteasome (By similarity) | thymus, brain and testes associated; May play a role in spermatid differentiation (By similarity). Modulates thymic stromal cell proliferation and thymus function (By similarity) | 0.536 |
CDKN1C | C7orf49 | ENSP00000411552 | ENSP00000376823 | cyclin-dependent kinase inhibitor 1C (p57, Kip2); Potent tight-binding inhibitor of several G1 cyclin/CDK complexes (cyclin E-CDK2, cyclin D2-CDK4, and cyclin A-CDK2) and, to lesser extent, of the mitotic cyclin B-CDC2. Negative regulator of cell proliferation. May play a role in maintenance of the non- proliferative state throughout life | chromosome 7 open reading frame 49; May act as a regulator of proteasome (By similarity) | 0.633 |
CDKN1C | TBATA | ENSP00000411552 | ENSP00000299290 | cyclin-dependent kinase inhibitor 1C (p57, Kip2); Potent tight-binding inhibitor of several G1 cyclin/CDK complexes (cyclin E-CDK2, cyclin D2-CDK4, and cyclin A-CDK2) and, to lesser extent, of the mitotic cyclin B-CDC2. Negative regulator of cell proliferation. May play a role in maintenance of the non- proliferative state throughout life | thymus, brain and testes associated; May play a role in spermatid differentiation (By similarity). Modulates thymic stromal cell proliferation and thymus function (By similarity) | 0.561 |
COL10A1 | C7orf49 | ENSP00000243222 | ENSP00000376823 | collagen, type X, alpha 1; Type X collagen is a product of hypertrophic chondrocytes and has been localized to presumptive mineralization zones of hyaline cartilage | chromosome 7 open reading frame 49; May act as a regulator of proteasome (By similarity) | 0.610 |
COL10A1 | PRKG2 | ENSP00000243222 | ENSP00000264399 | collagen, type X, alpha 1; Type X collagen is a product of hypertrophic chondrocytes and has been localized to presumptive mineralization zones of hyaline cartilage | protein kinase, cGMP-dependent, type II | 0.440 |
CTNND2 | AMHR2 | ENSP00000307134 | ENSP00000257863 | catenin (cadherin-associated protein), delta 2 | anti-Mullerian hormone receptor, type II; On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for anti-Muellerian hormone | 0.563 |
CTNND2 | C7orf49 | ENSP00000307134 | ENSP00000376823 | catenin (cadherin-associated protein), delta 2 | chromosome 7 open reading frame 49; May act as a regulator of proteasome (By similarity) | 0.690 |
ERCC6L2 | C7orf49 | ENSP00000288985 | ENSP00000376823 | excision repair cross-complementing rodent repair deficiency, complementation group 6-like 2 | chromosome 7 open reading frame 49; May act as a regulator of proteasome (By similarity) | 0.613 |